Alberto Serrano-Pozo, MD PhD
Affiliations: | 2008-2013 | Neurology | Massachusetts General Hospital, Boston, MA |
2013-2017 | Neurology | University of Iowa Hospitals & Clinics, Iowa City, IA, United States | |
2017- | Neurology | Massachusetts General Hospital, Boston, MA |
Area:
Alzheimer's disease, Lewy body disease, Frontotemporal Lobar Degenerations, Vascular dementias, NeurologyWebsite:
https://www.serranopozolab.orgGoogle:
"https://scholar.google.com/citations?user=30BafM12Qf8C&hl=en"Mean distance: (not calculated yet)
Parents
Sign in to add mentorEulogio Gil-Néciga | grad student | 2002-2008 | University Hospital Virgen del Rocío, Seville (Spain) | |
(Master clinician) | ||||
Bradley T. Hyman | post-doc | 2008-2013 | Harvard Medical School - Massachusetts General Hospital |
Children
Sign in to add traineeAyush Noori | research assistant | 2019- | MGH |
Molly A. Healey | research assistant | 2022- | MGH |
Jordan D. Marks | research assistant | 2018-2019 | MGH |
Srinija Alla | research assistant | 2019-2021 | MGH |
Methasit Jaisa-aad | post-doc | 2022- | MGH |
Yaxing Gui | post-doc | 2017-2018 | MGH |
Clara Muñoz-Castro | post-doc | 2021-2023 | MGH |
Collaborators
Sign in to add collaboratorJing Qian | collaborator | 2017- | U Mass Amherst |
Sudeshna Das | collaborator | 2019- | MGH |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Das S, Li Z, Noori A, et al. (2020) Meta-analysis of mouse transcriptomic studies supports a context-dependent astrocyte reaction in acute CNS injury versus neurodegeneration. Journal of Neuroinflammation. 17: 227 |
Dujardin S, Commins C, Lathuiliere A, et al. (2020) Tau molecular diversity contributes to clinical heterogeneity in Alzheimer's disease. Nature Medicine |
Calvo-Rodriguez M, Hou SS, Snyder AC, et al. (2020) Increased mitochondrial calcium levels associated with neuronal death in a mouse model of Alzheimer's disease. Nature Communications. 11: 2146 |
Serrano-Pozo A, Growdon JH. (2019) Is Alzheimer's Disease Risk Modifiable? Journal of Alzheimer's Disease : Jad. 67: 795-819 |
Pérez-Nievas BG, Serrano-Pozo A. (2019) Editorial: The Role of Glia in Alzheimer's Disease. Frontiers in Neurology. 9: 1161 |
Perez-Nievas BG, Serrano-Pozo A. (2018) Deciphering the Astrocyte Reaction in Alzheimer's Disease. Frontiers in Aging Neuroscience. 10: 114-114 |
Serrano-Pozo A, Aldridge GM, Zhang Q. (2017) Four Decades of Research in Alzheimer's Disease (1975-2014): A Bibliometric and Scientometric Analysis. Journal of Alzheimer's Disease : Jad |
Serrano-Pozo A, Sánchez-García MA, Heras-Garvín A, et al. (2017) Acute and Chronic Sustained Hypoxia Do Not Substantially Regulate Amyloid-β Peptide Generation In Vivo. Plos One. 12: e0170345 |
Serrano-Pozo A, Qian J, Muzikansky A, et al. (2016) Thal Amyloid Stages Do Not Significantly Impact the Correlation Between Neuropathological Change and Cognition in the Alzheimer Disease Continuum. Journal of Neuropathology and Experimental Neurology |
Serrano-Pozo A, Betensky RA, Frosch MP, et al. (2015) Plaque-Associated Local Toxicity Increases over the Clinical Course of Alzheimer Disease. The American Journal of Pathology |